Literature DB >> 30312409

In vitro activity of seven β-lactams including ceftolozane/tazobactam and ceftazidime/avibactam against Burkholderia cepacia complex, Burkholderia gladioli and other non-fermentative Gram-negative bacilli isolated from cystic fibrosis patients.

Clémence Massip1,2, Chloé Mathieu1,3, Cécile Gaudru1,2, Véronique Miaut1,4, Pauline Floch1,2, Eric Oswald1,2, Christine Segonds4, Hélène Guet-Revillet1,2,4.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 30312409     DOI： 10.1093/jac/dky423

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN： 0305-7453            Impact factor:   5.790


× No keyword cloud information.
  6 in total

1.  "Switching Partners": Piperacillin-Avibactam Is a Highly Potent Combination against Multidrug-Resistant Burkholderia cepacia Complex and Burkholderia gladioli Cystic Fibrosis Isolates.

Authors:  Elise T Zeiser; Scott A Becka; Brigid M Wilson; Melissa D Barnes; John J LiPuma; Krisztina M Papp-Wallace
Journal:  J Clin Microbiol       Date:  2019-07-26       Impact factor: 5.948

Review 2.  New β-Lactam-β-Lactamase Inhibitor Combinations.

Authors:  Dafna Yahav; Christian G Giske; Alise Grāmatniece; Henrietta Abodakpi; Vincent H Tam; Leonard Leibovici
Journal:  Clin Microbiol Rev       Date:  2020-11-11       Impact factor: 26.132

Review 3.  Burkholderia cepacia Complex Bacteria: a Feared Contamination Risk in Water-Based Pharmaceutical Products.

Authors:  Mariana Tavares; Mariya Kozak; Alexandra Balola; Isabel Sá-Correia
Journal:  Clin Microbiol Rev       Date:  2020-04-15       Impact factor: 26.132

4.  Management of initial colonisations with Burkholderia species in France, with retrospective analysis in five cystic fibrosis Centres: a pilot study.

Authors:  Vianney Gruzelle; Hélène Guet-Revillet; Christine Segonds; Stéphanie Bui; Julie Macey; Raphaël Chiron; Marine Michelet; Marlène Murris-Espin; Marie Mittaine
Journal:  BMC Pulm Med       Date:  2020-06-05       Impact factor: 3.317

5.  Activity of Imipenem-Relebactam against Multidrug- and Extensively Drug-Resistant Burkholderia cepacia Complex and Burkholderia gladioli.

Authors:  Scott A Becka; Elise T Zeiser; John J LiPuma; Krisztina M Papp-Wallace
Journal:  Antimicrob Agents Chemother       Date:  2021-08-09       Impact factor: 5.191

6.  In Vitro Activity of 22 Antibiotics against Achromobacter Isolates from People with Cystic Fibrosis. Are There New Therapeutic Options?

Authors:  Clémence Beauruelle; Claudie Lamoureux; Arsid Mashi; Sophie Ramel; Jean Le Bihan; Thomas Ropars; Anne Dirou; Anandadev Banerjee; Didier Tandé; Hervé Le Bars; Geneviève Héry-Arnaud
Journal:  Microorganisms       Date:  2021-11-30
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.